Per Stenkrona Selected Research

Vortioxetine

10/2013

5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Per Stenkrona Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2017
2	Neuroinflammatory Diseases 03/2017 - 04/2013
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Neoplasms (Cancer) 12/2021
1	Schizophrenia (Dementia Praecox) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Cognitive Dysfunction 01/2018
1	Antisocial Personality Disorder (Antisocial Personality) 01/2018
1	Gliosis 03/2017
1	Mood Disorders (Mood Disorder) 10/2013
1	Multiple Sclerosis 04/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2013
2	EnzymesIBA 01/2020 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2013
1	Glycoproteins (Glycoprotein)IBA 12/2022
1	AZD1390IBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	SCH 23390IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2019
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	Amyloid beta-PeptidesIBA 01/2018
1	Monoamine Oxidase (MAO)IBA 03/2017
1	sembragilineIBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2017
1	VortioxetineIBA 10/2013
1	N- (5- fluoro- 2- phenoxyphenyl)- N- (2- fluoroethyl- 5- methoxybenzyl)acetamideIBA 04/2013
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 04/2013

Therapy/Procedure

1	Radiotherapy 12/2021
1	Oral Administration 03/2017